Drug Profile


Latest Information Update: 11 Dec 2003

Price : $50

At a glance

  • Originator Inflammatics (CEASED)
  • Class Antirheumatics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 28 Aug 2002 Discontinued - Phase-I/II for Rheumatoid arthritis in USA (Injection)
  • 04 Feb 1999 Phase-I/II clinical trials for Rheumatoid arthritis in USA (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top